Cytosolic phospholipase A2 (cPLA2) distribution in murine brain and functional studies indicate that cPLA2 does not participate in muscarinic receptor-mediated signaling in neurons.
Cytosolic phospholipase A2 (cPLA2) catalyzes the selective release of arachidonic acid from the sn-2 position of membrane phospholipids and has been suggested as an effector in the receptor-mediated release of arachidonic acid in signal transduction. The potential role of cPLA2 as an effector in muscarinic acetylcholine receptor signaling was investigated through ectopic expression of either the m1 or m5 receptor in combination with cPLA2 in COS-1, CHO and U-373 MG cell lines. U-373 MG and COS-1 cells express undetectable or very low levels of cPLA2. CHO cell extracts are characterized by a significant endogenous PLA2 activity that was increased over 20-fold following transient expression with cPLA2 cDNA. However, in none of the cells lines did the co-expression of muscarinic receptor and cPLA2 result in a significant increase in muscarinic receptor-mediated arachidonic acid release over cells expressing muscarinic receptor alone. The distribution of cPLA2 mRNA and cPLA2 immunoreactivity in murine brain were determined in order to investigate a potential role for cPLA2 in neurotransmission. cPLA2 mRNA was expressed in white matter, including cells contained within linear arrays characteristic of interfascicular oligodendrocytes. cPLA2 immunoreactivity in white matter was evident throughout the processes of fibrous astrocytes. cPLA2 expression in gray matter was confined to astrocytes at the pial surface of the brain. cPLA2 mRNA was detected in pia mater, both at the brain surface and inner core of the choroid plexus. cPLA2 may not be directly linked to neurotransmission since enzyme expression, mRNA, and cPLA2 immunoreactivity were undetectable in neurons of murine brain. Support or regulation of neurotransmission may be provided through the activity of cPLA2 in glial cells.
Lautens
L L
LL
Department of Biological Sciences, Neurobiology Program, Ohio University, Athens, OH 45701, USA.
Chiou
X G
XG
Sharp
J D
JD
Young
W S
WS
Sprague
D L
DL
Ross
L S
LS
Felder
C C
CC
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D001921:Brain / Q000201:enzymology*; D016466:CHO Cells; D019556:COS Cells; D002831:Choroid Plexus / Q000166:cytology / Q000201:enzymology; D006224:Cricetinae; D003600:Cytosol / Q000201:enzymology; D015870:Gene Expression / Q000502:physiology; D005904:Glial Fibrillary Acidic Protein / Q000032:analysis; D017403:In Situ Hybridization; D008297:Male; D051379:Mice; D009474:Neurons / Q000737:chemistry / Q000201:enzymology*; D009836:Oligodendroglia / Q000737:chemistry / Q000201:enzymology; D010741:Phospholipases A / Q000235:genetics / Q000378:metabolism*; D054467:Phospholipases A2; D010841:Pia Mater / Q000166:cytology / Q000201:enzymology; D012333:RNA, Messenger / Q000032:analysis; D011976:Receptors, Muscarinic / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D014162:Transfection
D005904:Glial Fibrillary Acidic Protein; D012333:RNA, Messenger; D011976:Receptors, Muscarinic; D016718:Arachidonic Acid; D010741:Phospholipases A; D054467:Phospholipases A2